alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and scopolamine hydrobromide

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with scopolamine hydrobromide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Layer, RT; Uretsky, NJ; Wallace, LJ1
Dikranian, K; Farber, NB; Heinkel, C; Jiang, XP; Kim, SH1
Alkalay, D; Brandeis, R; Cohen, G; Rabinovitz, I; Raveh, L; Sonego, H; Weissman, BA1
Carelli, V; Di Rienzo, B; Liberatore, F; Marra, R; Rispoli, V; Rotiroti, D; Scipione, L; Tortorella, S1
Del Arco, A; Mora, F; Segovia, G1

Trials

1 trial(s) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and scopolamine hydrobromide

ArticleYear
Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction.
    Neurotoxicology, 2002, Volume: 23, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cognition Disorders; Cyclopentanes; Escape Reaction; Hypoxia, Brain; Male; Maze Learning; Prosencephalon; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine; Soman; Swimming

2002

Other Studies

4 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and scopolamine hydrobromide

ArticleYear
Effects of morphine in the nucleus accumbens on stimulant-induced locomotion.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Caffeine; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine Agents; Glutamine; Ibotenic Acid; Male; Morphine; Motor Activity; Neural Pathways; Nucleus Accumbens; Oligopeptides; Picrotoxin; Rats; Scopolamine; Synaptic Transmission

1991
Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity.
    Molecular psychiatry, 2002, Volume: 7, Issue:1

    Topics: Adrenergic alpha-Agonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Carbachol; Carbazoles; Cerebral Cortex; Clonidine; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Kainic Acid; Models, Neurological; Muscarinic Antagonists; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Phenazocine; Prosencephalon; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Scopolamine

2002
Electroencephalographic effects induced by choline pivaloyl esters in scopolamine-treated or nucleus basalis magnocellularis lesioned rats.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 78, Issue:4

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Basal Nucleus of Meynert; Choline; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Electroencephalography; Esters; Injections, Intraperitoneal; Male; Parasympathetic Nervous System; Parasympatholytics; Parietal Lobe; Rats; Rats, Wistar; Scopolamine

2004
Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
    Psychopharmacology, 2008, Volume: 201, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cholinergic Antagonists; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Flupenthixol; Glutamic Acid; Homovanillic Acid; Injections, Intraventricular; Male; Mecamylamine; Microinjections; Motor Activity; Muscarinic Antagonists; N-Methylaspartate; Nicotinic Antagonists; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Scopolamine

2008